Sandro Corti, MD
Neurology · Fort Myers, FLNPI 1538503131
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $651 and has fallen 95.0% since, to $32 in 2022. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 62 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$112
- AbbVie$92
- Genentech USA, Inc.$91
- Jazz Pharmaceuticals Inc.$88
- Tanabe Pharma America, Inc.$73
- AstraZeneca$72
- plus $366 from 14 others
What the payments were for
- Speaking & faculty fees$131%
- Food & beverage$88099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 7 | $112 |
| AbbVie | 7 | $92 |
| Genentech USA, Inc. | 7 | $91 |
| Jazz Pharmaceuticals Inc. | 6 | $88 |
| Tanabe Pharma America, Inc. | 5 | $73 |
| AstraZeneca | 5 | $72 |
| Adamas Pharmaceuticals, Inc. | 4 | $59 |
| Teva Pharmaceuticals USA, Inc. | 4 | $54 |
| UCB, Inc. | 3 | $42 |
| Aquestive Therapeutics, Inc. | 2 | $37 |
| Greenwich Biosciences, Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Amgen | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Harmony Biosciences LLC | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Promius Pharma LLC | 1 | $14 |
| Validus Pharmaceuticals LLC | 1 | $13 |
| Acorda Therapeutics, Inc | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $11 |
How this compares
$893 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Fort Myers
- Gustavo SilvaFort Myers$165K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.